Literature DB >> 16822877

Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis.

Hiu-Fung Yuen1, Yuen-Piu Chan, Michelle Lok-Yee Wong, Wei-Kei Kwok, Ka-Kui Chan, Pin-Yin Lee, Gopesh Srivastava, Simon Ying-Kit Law, Yong-Chuan Wong, Xianghong Wang, Kwok-Wah Chan.   

Abstract

BACKGROUND: The antiapoptotic and epithelial-mesenchymal transition activities of Twist have been implicated in the neoplastic transformation and the development of metastasis, respectively. Upregulation of Twist, described in several types of human cancer, also acts as a prognostic marker of poor outcome. AIM: To investigate Twist expression in oesophageal squamous cell carcinoma (SCC) and its prognostic value in a Chinese cohort of patients with oesophageal SCC.
METHODS: Twist expression in primary oesophageal SCC of 87 Chinese patients was investigated by immunohistochemical staining. Twist protein level in one immortalised normal oesophageal epithelial cell line and six oesophageal SCC cell lines was measured by western blot analysis. Twist mRNA level in 30 pairs of frozen specimens of primary oesophageal SCC and non-neoplastic oesophageal epithelium from the upper resection margin of corresponding oesophagectomy specimen was also determined by semiquantitative reverse transcription-PCR.
RESULTS: It was found that Twist was upregulated in oesophageal SCC cell lines, and its mRNA and protein levels were both increased in oesophageal SCC and the non-neoplastic oesophageal epithelium (p<0.001). In addition, a high level of Twist expression in oesophageal SCC was significantly associated with a greater risk for the patient of developing distant metastasis within 1 year of oesophagectomy (OR 3.462, 95% CI 1.201 to 9.978; p=0.022).
CONCLUSIONS: Our results suggest that upregulation of Twist plays a role in the neoplastic transformation to oesophageal SCC and subsequent development of distant metastasis. Twist may serve as a useful prognostic marker for predicting the development of distant metastasis in oesophageal SCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822877      PMCID: PMC1994533          DOI: 10.1136/jcp.2006.039099

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implications.

Authors:  Shinsuke Takeno; Tsuyoshi Noguchi; Shoichi Fumoto; Yasuhiko Kimura; Tomotaka Shibata; Katsunobu Kawahara
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

2.  The clinical significance of twist expression in nasopharyngeal carcinoma.

Authors:  Li-Bing Song; Wen-Ting Liao; Hai-Qiang Mai; Hui-Zhong Zhang; Ling Zhang; Man-Zhi Li; Jing-Hui Hou; Li-Wu Fu; Wen-Lin Huang; Yi-Xin Zeng; Mu-Sheng Zeng
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer.

Authors:  Tracey A Martin; Amit Goyal; Gareth Watkins; Wen G Jiang
Journal:  Ann Surg Oncol       Date:  2005-04-19       Impact factor: 5.344

5.  Human Dermo-1 has attributes similar to twist in early bone development.

Authors:  M S Lee; G Lowe; S Flanagan; K Kuchler; C A Glackin
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

6.  Twist is a potential oncogene that inhibits apoptosis.

Authors:  R Maestro; A P Dei Tos; Y Hamamori; S Krasnokutsky; V Sartorelli; L Kedes; C Doglioni; D H Beach; G J Hannon
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

7.  Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Yasuto Uchikado; Shoji Natsugoe; Hiroshi Okumura; Tetsuro Setoyama; Masataka Matsumoto; Sumiya Ishigami; Takashi Aikou
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

Review 8.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

9.  Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.

Authors:  Keith Hoek; David L Rimm; Kenneth R Williams; Hongyu Zhao; Stephan Ariyan; Aiping Lin; Harriet M Kluger; Aaron J Berger; Elaine Cheng; E Sergio Trombetta; Terence Wu; Michio Niinobe; Kazuaki Yoshikawa; Gregory E Hannigan; Ruth Halaban
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

10.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

View more
  53 in total

1.  Negative Regulatory Role of TWIST1 on SNAIL Gene Expression.

Authors:  Mohammad Mahdi Forghanifard; Sima Ardalan Khales; Moein Farshchian; Abolfazl Rad; Masoud Homayouni-Tabrizi; Mohammad Reza Abbaszadegan
Journal:  Pathol Oncol Res       Date:  2016-07-20       Impact factor: 3.201

2.  Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma.

Authors:  Paras Jethwa; Mushal Naqvi; Robert G Hardy; Neil-A Hotchin; Sally Roberts; Robert Spychal; Chris Tselepis
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

3.  Expression and significance of twist, E-cadherin, and N-cadherin in gastrointestinal stromal tumors.

Authors:  Jie Ding; Zhongmin Zhang; Yang Pan; Guoqing Liao; Liang Zeng; Senlin Chen
Journal:  Dig Dis Sci       Date:  2012-05-11       Impact factor: 3.199

4.  Down-regulation of TWIST decreases migration and invasion of laryngeal carcinoma Hep-2 cells by regulating the E-cadherin, N-cadherin expression.

Authors:  Liang Yu; Hui-zheng Li; Su-mei Lu; Jia-jun Tian; Ju-ke Ma; Hai-bo Wang; Wei Xu
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-07       Impact factor: 4.553

5.  Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.

Authors:  Dong-Yuan Zhu; Qi-Sen Guo; Yan-Liang Li; Bin Cui; Jun Guo; Ji-Xiao Liu; Peng Li
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

6.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

Authors:  Jeff H Tsai; Joana Liu Donaher; Danielle A Murphy; Sandra Chau; Jing Yang
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

7.  Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

Authors:  Ke Yin; Qiande Liao; Hongbo He; Da Zhong
Journal:  Med Oncol       Date:  2012-07-31       Impact factor: 3.064

8.  Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.

Authors:  Ken Sasaki; Shoji Natsugoe; Sumiya Ishigami; Masataka Matsumoto; Hiroshi Okumura; Tetsuro Setoyama; Yasuto Uchikado; Yoshiaki Kita; Kiyokazu Tamotsu; Akihiko Sakamoto; Tetsuhiro Owaki; Takashi Aikou
Journal:  J Exp Clin Cancer Res       Date:  2009-12-21

9.  Expression of TWIST1, Snail, Slug, and NF-κB and methylation of the TWIST1 promoter in mammary phyllodes tumor.

Authors:  Sung-Im Do; Ji Yeon Kim; So Young Kang; Jae Joon Lee; Jeong Eon Lee; Seok Jin Nam; Eun Yoon Cho
Journal:  Tumour Biol       Date:  2012-11-14

10.  Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.

Authors:  George Z Cheng; Wei Zhou Zhang; Mei Sun; Qi Wang; Domenico Coppola; Mena Mansour; Li Mei Xu; Carliann Costanzo; Jin Q Cheng; Lu-Hai Wang
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.